Page not found

Search results

  1. Discovery Vanderbilt invests in three faculty-initiated startups: HeroWear, IDBiologics and Virtuoso

    ... the  Center for Rehabilitation Engineering and Assistive Technology  by  Karl Zelik , associate professor of mechanical ... evaluation, potential licensing and clinical development as novel medicines that could treat COVID-19 or prevent infection from the ...

    sommers - 05/23/2023 - 12:14pm

  2. Theralink® Acquires Exclusive Landmark Immunotherapy Patent including Biomarker from Vanderbilt University

    ... or the “Company”) , a precision oncology company with a novel phosphoprotein and protein assay for breast cancer, today announced that ... and protein biomarker platform and LDTs, Theralink’s technology targets multiple areas of oncology and drug development. In addition ...

    sommers - 04/24/2023 - 1:45pm

  3. Novartis Institutes for BioMedical Research (NIBR) Global Scholars Program

    ... Through this program, NIBR will support projects focused on novel science that can be translated to discovery research.  Program ... All proposals must be reviewed by Vanderbilt Center for Technology Transfer and Commercialization (CTTC) before submission to NGSP.   ...

    sommers - 04/07/2023 - 12:30pm

  4. How to Start a University Spinoff Biotech: From Concept to Commercialization

    ... Family Center for Applied Innovation and the Center for Technology Transfer & Commercialization present the next presentation from the ... He developed an RSV reverse genetics platform technology and novel strategies and methods for making vaccine candidates by synthetic ...

    sommers - 04/03/2023 - 12:32pm

  5. Vanderbilt and Deerfield Management celebrate Ancora Innovation, a collaboration for accelerating drug discovery, potential life-changing therapeutics

    ... cures for patients.” Vanderbilt’s Center for Technology Transfer and Commercialization within the Office of the Vice Provost ... resources from Deerfield, including projects to develop novel treatments for  dystonia and other movement disorders ,  opioid use ...

    sommers - 03/03/2023 - 1:30pm

  6. Screening System to Identify 5 Alpha Reductase Inhibitors

    ... goal is to reduce DHT levels in targeted biological systems. Novel inhibitors have the potential to contribute to the development of therapies for ...

    cttc_admin - 12/14/2023 - 7:45am

  7. Company co-founded by Vanderbilt professor receives distinguished FDA breakthrough device designation for minimally invasive surgical tool

    ... to doctors and patients. Such designations are granted to novel medical devices that have the potential to provide more effective ... conditions. EndoTheia’s device leverages foundational technology that was originally invented at Vanderbilt and the University of ...

    sommers - 01/11/2023 - 10:03am

  8. Center for Technology Transfer and Commercialization breaks records in leveraging innovation and discovery at Vanderbilt

    ... 10/10/2022 The  Vanderbilt Center for Technology Transfer and Commercialization  generated more than $100 million ... U.S. patents were issued. Among the issued patents include novel components needed to treat sickle cell disease and Parkinson’s disease, ...

    sommers - 10/10/2022 - 10:35am

  9. La Jolla Pharmaceutical Company and Vanderbilt University Enter Exclusive Research and License Agreement Covering Novel BMP Type-I Receptor Inhibitors

    ... to research and develop small-molecule BMP type-I receptor inhibitors designed to aid in treatment of rare genetic disorders. Below is ... work hard to translate their pioneering discoveries into novel treatments for patients in need.” About La Jolla ...

    steelmk - 10/02/2015 - 10:45am

  10. Vanderbilt Inventor wins ASPET Award

    ... ASPET said Lindsley was honored for “his pioneering use of technology-enabled synthesis, which led to fundamental and transforming effects ... Craig Lindsley's available technologies: Novel PLD Inhibitors Small Molecule Theraputics That Target the ...

    steelmk - 01/13/2017 - 2:44pm